DC
KRSA

Diametric Capital’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Diametric Capital’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,741
Closed -$210K – 318
2022
Q3 		$210K Buy
1,741
+1
+0.1% +$17 0.11% 216
2022
Q2 		$134K Buy
1,740
+433
+33% +$6.2K 0.1% 219
2022
Q1 		$203K Buy
1,307
+589
+82% +$14.2K 0.11% 186
2021
Q4 		$173K Buy
718
+219
+44% +$10.3K 0.13% 139
2021
Q3 		$214K Sell
499
-75
-13% -$4.91K 0.17% 112
2021
Q2 		$313K Buy
+574
New +$35.9K 0.23% 97

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Diametric Capital's KRSA Position: Q4 2022 in Review

Diametric Capital sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2022, closing a stake of 1,741 shares — an estimated $210K sold.

Diametric Capital first reported a position in KRSA in Q2 2021 and held it in 6 quarters. The position peaked at $313K in Q2 2021. 33 funds tracked by Wall St. Rank hold KRSA as of Q4 2022.

  • Diametric Capital reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Diametric Capital sold 1,741 Korsana Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $210K.
  • Diametric Capital first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Diametric Capital's Korsana Biosciences, Inc. Common Stock position peaked at $313K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2022.

Based on Diametric Capital's 13F filing for Q4 2022, filed 29 Mar 2023.